Both in vitro and in vivo decrease of TXNIP expression by RES treatment or RNA interference blocked TXNIP expression and subsequently inhibited NLRP3 inflammasome activation in response to ischemia-induced AKI in DM. This evidence concerns the gene NLRP3 and diabetes mellitus.